Logo image of ZNH

CHINA SOUTHERN AIR-SPONS ADR (ZNH) Stock Fundamental Analysis

NYSE:ZNH - New York Stock Exchange, Inc. - US1694091091 - ADR - Currency: USD

33.08  +0.02 (+0.06%)

Fundamental Rating

1

Taking everything into account, ZNH scores 1 out of 10 in our fundamental rating. ZNH was compared to 23 industry peers in the Passenger Airlines industry. ZNH has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ZNH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZNH has reported negative net income.
In the past year ZNH had a positive cash flow from operations.
ZNH Yearly Net Income VS EBIT VS OCF VS FCFZNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10B -10B 20B 30B

1.2 Ratios

ZNH has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZNH Yearly ROA, ROE, ROICZNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 -10 -15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZNH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZNH Yearly Profit, Operating, Gross MarginsZNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 -10 15

More info and screens

0

2. Health

2.1 Basic Checks

ZNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZNH has been increased compared to 1 year ago.
The debt/assets ratio for ZNH is higher compared to a year ago.
ZNH Yearly Shares OutstandingZNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
ZNH Yearly Total Debt VS Total AssetsZNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100B 200B 300B

2.2 Solvency

ZNH has an Altman-Z score of -0.12. This is a bad value and indicates that ZNH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.12, ZNH is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.23 is on the high side and indicates that ZNH has dependencies on debt financing.
The Debt to Equity ratio of ZNH (2.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACCN/A
WACC7.75%
ZNH Yearly LT Debt VS Equity VS FCFZNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50B 100B

2.3 Liquidity

ZNH has a Current Ratio of 0.25. This is a bad value and indicates that ZNH is not financially healthy enough and could expect problems in meeting its short term obligations.
ZNH has a Current ratio of 0.25. This is amonst the worse of the industry: ZNH underperforms 86.96% of its industry peers.
ZNH has a Quick Ratio of 0.25. This is a bad value and indicates that ZNH is not financially healthy enough and could expect problems in meeting its short term obligations.
ZNH has a Quick ratio of 0.23. This is amonst the worse of the industry: ZNH underperforms 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.23
ZNH Yearly Current Assets VS Current LiabilitesZNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B 100B

More info and screens

4

3. Growth

3.1 Past

ZNH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.64%, which is quite impressive.
Looking at the last year, ZNH shows a very negative growth in Revenue. The Revenue has decreased by -11.73% in the last year.
ZNH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.41% yearly.
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-326.14%
Revenue 1Y (TTM)-11.73%
Revenue growth 3Y-10.88%
Revenue growth 5Y-2.41%
Sales Q2Q%9.01%

3.2 Future

The Earnings Per Share is expected to grow by 37.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, ZNH will show a quite strong growth in Revenue. The Revenue will grow by 19.70% on average per year.
EPS Next Y-67.27%
EPS Next 2Y45.13%
EPS Next 3Y37.19%
EPS Next 5YN/A
Revenue Next Year-10.62%
Revenue Next 2Y18.55%
Revenue Next 3Y19.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZNH Yearly Revenue VS EstimatesZNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B
ZNH Yearly EPS VS EstimatesZNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZNH. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 59.92 indicates a quite expensive valuation of ZNH.
ZNH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ZNH is more expensive than 65.22% of the companies in the same industry.
ZNH is valuated expensively when we compare the Price/Forward Earnings ratio to 22.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 59.92
ZNH Price Earnings VS Forward Price EarningsZNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZNH Per share dataZNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ZNH's earnings are expected to grow with 37.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.13%
EPS Next 3Y37.19%

More info and screens

0

5. Dividend

5.1 Amount

ZNH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINA SOUTHERN AIR-SPONS ADR

NYSE:ZNH (2/2/2023, 8:04:00 PM)

33.08

+0.02 (+0.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-30 2022-08-30/dmh
Earnings (Next)03-30 2023-03-30/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.99B
Analysts75
Price Target36.36 (9.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-24.66%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.21%
Min EPS beat(2)11.21%
Max EPS beat(2)11.21%
EPS beat(4)2
Avg EPS beat(4)-14.54%
Min EPS beat(4)-62.02%
Max EPS beat(4)11.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)22.13%
Min Revenue beat(2)4.82%
Max Revenue beat(2)39.44%
Revenue beat(4)3
Avg Revenue beat(4)12.18%
Min Revenue beat(4)-6.11%
Max Revenue beat(4)39.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.04%
PT rev (3m)26.58%
EPS NQ rev (1m)23.58%
EPS NQ rev (3m)23.58%
EPS NY rev (1m)4.43%
EPS NY rev (3m)-18.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 59.92
P/S 0.88
P/FCF N/A
P/OCF 10.87
P/B 1.58
P/tB 1.81
EV/EBITDA N/A
EPS(TTM)-5.19
EYN/A
EPS(NY)0.55
Fwd EY1.67%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)3.04
OCFY9.2%
SpS37.79
BVpS20.89
TBVpS18.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.23
Altman-Z -0.12
F-Score3
WACC7.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-326.14%
EPS Next Y-67.27%
EPS Next 2Y45.13%
EPS Next 3Y37.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.73%
Revenue growth 3Y-10.88%
Revenue growth 5Y-2.41%
Sales Q2Q%9.01%
Revenue Next Year-10.62%
Revenue Next 2Y18.55%
Revenue Next 3Y19.7%
Revenue Next 5YN/A
EBIT growth 1Y-266.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.02%
EBIT Next 3Y76.23%
EBIT Next 5YN/A
FCF growth 1Y-130.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.63%
OCF growth 3Y-11.95%
OCF growth 5Y-12.71%